Related Experiment Video
Updated: Jun 19, 2026

05:31
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
Published on: May 9, 2021
[Ovarian stimulation and follicular puncture risks].
P Merviel1, R Cabry, V Boulard
1Service de gynécologie-obstétrique et médecine de la reproduction, CHU d'Amiens, 124, rue Camille-Desmoulins, 80054 Amiens cedex 1, France. Merviel.Philippe@chu-amiens.fr
Gynecologie, Obstetrique & Fertilite
|October 13, 2009
Summary
Ovarian stimulation and follicular puncture in assisted reproductive technology (ART) carry risks like OHSS and infection. Careful planning is crucial for preventing these complications during fertility treatments.
Area of Science:
- Reproductive endocrinology and infertility treatments.
- Medical risk assessment and patient safety in assisted reproductive technology (ART).
Context:
- Assisted reproductive technology (ART) procedures, including ovarian stimulation and follicular puncture, involve inherent risks.
- Patient safety protocols are essential for managing potential complications during ART.
Purpose:
- To outline the potential risks associated with ovarian stimulation and follicular puncture in ART.
- To emphasize the importance of risk management and prevention strategies in ART procedures.
Summary:
- Key risks include ovarian hyperstimulation syndrome (OHSS), thromboembolic events, and carcinologic concerns.
- Procedural risks of follicular puncture encompass anesthesia, hemorrhage, and infection.
- Endometriomas may elevate the risk of infection during follicular puncture.
Impact:
- Informed patient consent and optimized treatment protocols can mitigate ART-related risks.
- Proactive management strategies are vital for improving ART safety and outcomes.
- Understanding these risks allows for better preparation and potentially reduces adverse events in fertility treatments.
More Related Videos
Related Concept Videos
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

